Digital Health Growth Investors & VC Firms
459 firms in this list, with a median first check of $2M. 139 of them lead rounds. Generated from verified public data and updated continuously.
Nordic Capital
StockholmGrowth–Late Stage
12 people
Oberland Capital
New YorkGrowth–Late Stage
20 people
Quan Capital
ShanghaiSeed–Growth
17 people
Accelmed Partners
MiamiSeries A–Growth
10 people
New Alliance Capital
ShanghaiSeed–Late Stage
25 people
Kyoto University Innovation Capital
KyotoPre-Seed–Growth
MDI Ventures
JakartaPre-Seed–Growth
12 people
BIOSPRING PARTNERS
New YorkGrowth
22 people
MSD Global Health Innovation Fund
RahwaySeries A–Late Stage$2M – $10M
10 people
Serpentine Ventures
ZürichSeed–Growth
7 people
Beltone Private Equity
CairoGrowth
15 people
DeepTech & Climate Fonds
MunichSeries A–Growth$5.5M – $55M
15 people
Sciety
StockholmSeed–Growth
21 people
Lauxera Capital Partners
ParisGrowth$22M – $110M
17 people
Brookstreet Equity Partners
LondonSeries A–Late Stage
22 people
BootstrapLabs
Silicon ValleySeed–Growth$100K – $6M
11 people
Crew Capital
New YorkPre-Seed–Growth$500K – $2M
5 people
Impact Expansion Management Sarl
BrusselsGrowth$5.4M – $32.4M
17 people
Equality Asset Management
BostonGrowth$25M – $150M
16 people
Bailador Technology Investments
SydneyGrowth$3.3M – $13.2M
15 people
DNA Capital
São PauloSeed–Late Stage$100K – $5M
15 people
Whitecap Venture Partners
TorontoSeed–Growth$1.5M – $3.6M
12 people
Alkemi Growth Capital
New DelhiPre-Seed–Growth
15 people
HBM Partners
ZugSeed–Late Stage$5M – $50M
6 people
Related lists
Growth Investors & VC Firms (4263)Growth Investors & VC Firms in North America (2121)Growth Investors & VC Firms in United States (1837)Growth Investors & VC Firms in Europe (1633)Digital Health Investors & VC Firms (1544)Growth Investors & VC Firms in Global (1377)Healthtech Growth Investors & VC Firms (1269)Growth Investors & VC Firms in Asia-Pacific (1257)Digital Health Seed Investors & VC Firms (1237)Enterprise Software Growth Investors & VC Firms (1193)
Data sourced from public filings and firms' own websites — see our methodology.




































































































